Daner Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$842K Buy
697
+5
+0.7% +$5.11K 0.46% 31
2026
Q1
$685K Sell
692
-122
-15% -$124K 0.4% 38
2025
Q4
$835K Buy
814
+19
+2% +$18.2K 0.51% 27
2025
Q3
$639K Buy
795
+71
+10% +$52.8K 0.41% 34
2025
Q2
$463K Buy
+724
New +$563K 0.32% 42
2024
Q4
$402K Buy
+488
New +$404K 0.29% 36

Other funds holding LLY

Daner Wealth Management's LLY Position: Q2 2026 in Review

Daner Wealth Management increased its Eli Lilly (LLY) stake by 0.72% in Q2 2026, buying an estimated $5.11K and bringing the position to 697 shares worth $842K. The position accounts for 0.46% of the portfolio, ranked #31.

Daner Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Daner Wealth Management held 697 shares of Eli Lilly worth $842K as of Q2 2026.
  • Daner Wealth Management bought 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.46% of Daner Wealth Management's portfolio in Q2 2026, its #31 holding.
  • Daner Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Daner Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.